Mesalamine
Common brands: Pentasa, Lialda, Apriso, Canasa, Rowasa
Top reporter: Takeda Pharmaceuticals America, Inc.
Aminosalicylate [EPC]Corticosteroid [EPC]Tumor Necrosis Factor Blocker [EPC]Integrin Receptor Antagonist [EPC]Purine Antimetabolite [EPC]
54,800
Total Reports
25,854
Serious Reports
2,632
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.80%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Mesalamine.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | OFF LABEL USE | 9,022 | |
| 2 | DRUG INEFFECTIVE | 7,018 | |
| 3 | COLITIS ULCERATIVE | 6,525 | |
| 4 | DIARRHOEA | 4,840 | |
| 5 | CONDITION AGGRAVATED | 4,526 | |
| 6 | FATIGUE | 3,773 | |
| 7 | ABDOMINAL PAIN | 3,679 | |
| 8 | HAEMATOCHEZIA | 3,582 | |
| 9 | NAUSEA | 3,265 | |
| 10 | HEADACHE | 3,080 | |
| 11 | ARTHRALGIA | 2,898 | |
| 12 | PYREXIA | 2,855 | |
| 13 | CROHN^S DISEASE | 2,779 | |
| 14 | WEIGHT DECREASED | 2,689 | |
| 15 | PAIN | 2,646 | |
| 16 | MALAISE | 2,495 | |
| 17 | FREQUENT BOWEL MOVEMENTS | 2,447 | |
| 18 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 2,122 | |
| 19 | INTENTIONAL PRODUCT USE ISSUE | 2,035 | |
| 20 | VOMITING | 2,016 | |
| 21 | DYSPNOEA | 1,767 | |
| 22 | ASTHENIA | 1,731 | |
| 23 | DIZZINESS | 1,727 | |
| 24 | RECTAL HAEMORRHAGE | 1,705 | |
| 25 | RASH | 1,700 | |
| 26 | WEIGHT INCREASED | 1,684 | |
| 27 | INJECTION SITE PAIN | 1,591 | |
| 28 | PNEUMONIA | 1,509 | |
| 29 | NASOPHARYNGITIS | 1,489 | |
| 30 | ABDOMINAL PAIN UPPER | 1,331 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.